metronidazole
- Product NDC
- 60760-539
- 11-digit product format
- 607600539
- Labeler code
- 60760
- Product ID
- 60760-539_50c8400f-2dff-8694-e063-6294a90ac938
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- metronidazole
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- ST. MARY'S MEDICAL PARK PHARMACY
- Application
- ANDA206560
- Marketing category
- ANDA
- Marketing start
- 2022-06-17
- Substance
- METRONIDAZOLE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 60760-539 | 60760-539-40 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A206560-001 | METRONIDAZOLE | METRONIDAZOLE | 250MG | TABLET / ORAL | AB | 2016-11-16 | |
| A206560-002 | METRONIDAZOLE | METRONIDAZOLE | 500MG | TABLET / ORAL | AB | 2016-11-16 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A206560-001 | AB |
| A206560-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A206560-001 | METRONIDAZOLE | 250MG | TABLET / ORAL | AB | 2016-11-16 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A206560-002 | METRONIDAZOLE | 500MG | TABLET / ORAL | AB | 2016-11-16 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A206560-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A206560-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| metronidazole | METRONIDAZOLE | REMEDYREPACK INC. | d5784eeb-6b99-4e8a-847b-b0d1090ed48a | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | 206560 ANDA206560 |
| metronidazole | METRONIDAZOLE | ST. MARY'S MEDICAL PARK PHARMACY | e3a32908-9db1-6ca7-e053-2a95a90a82fb | 2026-05-01 | Boxed warning, Warnings, Adverse reactions | 206560 ANDA206560 60760-539 |
| metronidazole | METRONIDAZOLE | REMEDYREPACK INC. | b49a8ad0-2cf9-4386-8bf5-1b1df87b0022 | 2026-02-18 | Boxed warning, Warnings, Adverse reactions | 206560 ANDA206560 |
| metronidazole | METRONIDAZOLE | Sportpharm LLC | dc8e448e-ac4e-4efc-8851-c368e31b9d69 | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | 206560 ANDA206560 |
| metronidazole | METRONIDAZOLE | Preferred Pharmaceuticals Inc. | ab695a3e-1721-491a-97a2-c3f617a8d9fc | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | 206560 ANDA206560 |
| metronidazole | METRONIDAZOLE | Northwind Health Company, LLC | 06bd4afb-4a45-294c-e063-6394a90a7ab1 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 206560 ANDA206560 |
| metronidazole | METRONIDAZOLE | PD-Rx Pharmaceuticals, Inc. | 8f1de4ca-a005-4ca9-a43a-380429c80d6f | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | 206560 ANDA206560 |
| metronidazole | METRONIDAZOLE | Bryant Ranch Prepack | 356579f3-a9ed-49cf-bc0d-47b58a58cf85 | 2025-09-12 | Boxed warning, Warnings, Adverse reactions | 206560 ANDA206560 |
| metronidazole | METRONIDAZOLE | Viona Pharmaceuticals Inc | 0f108035-d2ab-49c1-9f8d-daae11f0efe0 | 2024-08-13 | Boxed warning, Warnings, Adverse reactions | 206560 ANDA206560 |
| METRONIDAZOLE | METRONIDAZOLE | Zydus Lifesciences Limited | f3ef765c-b531-4aaa-a86d-e32b7254ca48 | 2024-08-13 | Boxed warning, Warnings, Adverse reactions | 206560 ANDA206560 |
| metronidazole | METRONIDAZOLE | Bryant Ranch Prepack | 9e702861-87f5-4bc0-864d-317050020194 | 2024-08-12 | Boxed warning, Warnings, Adverse reactions | 206560 ANDA206560 |
| metronidazole | METRONIDAZOLE | Bryant Ranch Prepack | 1030e723-cde9-44a7-8dab-2f0932ffcc2c | 2024-08-12 | Boxed warning, Warnings, Adverse reactions | 206560 ANDA206560 |
| metronidazole | METRONIDAZOLE | Asclemed USA, Inc. | 89970965-a995-4ae4-a70b-bd2de38081e1 | 2024-04-26 | Boxed warning, Warnings, Adverse reactions | 206560 ANDA206560 |
| metronidazole | METRONIDAZOLE | NuCare Pharmaceuticals,Inc. | c2dbfec8-da5b-cd2b-e053-2a95a90ad17c | 2024-02-09 | Boxed warning, Warnings, Adverse reactions | 206560 ANDA206560 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- metronidazole
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| METRONIDAZOLE | 500 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 140QMO216E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 311681 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| e3a32908-9db1-6ca7-e053-2a95a90a82fb | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60760-539-14 | metronidazole | 14 in 1 BOTTLE, PLASTIC | TABLET | 14 | 4 | |
| 60760-539-40 | metronidazole | 40 in 1 BOTTLE, PLASTIC | TABLET | 40 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60760-539-14 | EA - Each | 60760-539 | e8fa175c-99ba-4e33-9f54-5a6cea7a0e59 | 1 | 2022-08-04 |
| 60760-539-40 | EA - Each | 60760-539 | 228e4cd4-aa12-48e0-b13e-0a74a47035f7 | 1 | 2023-05-05 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 311681 | metroNIDAZOLE 500 MG Oral Tablet | PSN | e3a32908-9db1-6ca7-e053-2a95a90a82fb | 4 |
| 311681 | metronidazole 500 MG Oral Tablet | SCD | e3a32908-9db1-6ca7-e053-2a95a90a82fb | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 60760-539-14 | 60760053914 | 14 TABLET in 1 BOTTLE, PLASTIC (60760-539-14) | 14 tablet | 2022-06-17 | 0000-00-00 | No | No | Current |
| 60760-539-40 | 60760053940 | 40 in 1 BOTTLE, PLASTIC | Historical |